Please login to the form below

Not currently logged in
Email:
Password:

Acorda appoints new CFO

Michael Rodgers replaces David Lawrence who becomes chief business officer

Acorda has reshuffled its senior business leadership, with Michael Rodgers appointed chief financial officer replacing David Lawrence who becomes chief business officer.

Rodgers joins from BG Medicine where he also served as chief financial officer. During his time at BG he led the company's initial public offering and helped launch its first product.

His previous roles include chief financial officer of Indevus Pharmaceuticals, where he stayed for 10 years before the company was acquired by Endo Pharmaceuticals.

Rodgers' predecessor as Acorda's chief financial officer David Lawrence moves to the newly-created role of chief business officer, where he will be responsible for the company's technical operations, project management, IT and facilities.

“We've grown rapidly over the past several years, and our internal operations need to keep pace with the demands of the business,” said Lawrence.

“I'm excited to take on this new challenge at Acorda, overseeing and optimising development of our business operations and infrastructure.”

This growth is led by six therapies in clinical studies that address a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic pain and heart failure. 

9th October 2013

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...